PRICE T ROWE ASSOCIATES INC /MD/ - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 87 filers reported holding VISTAGEN THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$5
+66.7%
33,9590.0%0.00%
Q4 2022$3
-99.9%
33,959
+89.1%
0.00%
Q3 2022$3,000
-96.2%
17,954
-79.9%
0.00%
Q2 2022$79,000
-28.2%
89,354
+1.1%
0.00%
Q1 2022$110,000
-33.3%
88,371
+4.7%
0.00%
Q4 2021$165,000
+7.8%
84,371
+51.0%
0.00%
Q3 2021$153,000
-14.5%
55,871
-1.6%
0.00%
Q2 2021$179,000
+113.1%
56,771
+43.7%
0.00%
Q1 2021$84,00039,5000.00%
Other shareholders

There were no reported owners of VISTAGEN THERAPEUTICS INC in Q4 2022.

NameSharesValueWeighting ↓
View complete list of VISTAGEN THERAPEUTICS INC shareholders